129 related articles for article (PubMed ID: 16818264)
1. Inactivation of CDKN2A, CDKN2B and MTAP in childhood B-lineage acute lymphobastic leukemia.
Beverloo HB
Haematologica; 2006 Jul; 91(7):865B. PubMed ID: 16818264
[No Abstract] [Full Text] [Related]
2. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
[TBL] [Abstract][Full Text] [Related]
3. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
[TBL] [Abstract][Full Text] [Related]
4. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
5. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
6. [Homozygous deletion and methylation of p16 and p15 gene in acute leukemia].
Chen W; Zhang W; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):474-6. PubMed ID: 11721412
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
[TBL] [Abstract][Full Text] [Related]
8. [Detection of hypermethylation of p15 gene in patients with acute leukemia by polymerase chain reaction].
Chen F; Zeng X
Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):250-2. PubMed ID: 11876990
[TBL] [Abstract][Full Text] [Related]
9. Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization.
Kamath A; Tara H; Xiang B; Bajaj R; He W; Li P
Cancer Genet Cytogenet; 2008 Jun; 183(2):117-20. PubMed ID: 18503831
[TBL] [Abstract][Full Text] [Related]
10. [Deletions and aberrant transcription of p16 and p15 genes in childhood acute lymphoblastic leukemia].
Fu G; Lu C; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):366-8. PubMed ID: 11721435
[TBL] [Abstract][Full Text] [Related]
11. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
Xu H; Zhang H; Yang W; Yadav R; Morrison AC; Qian M; Devidas M; Liu Y; Perez-Andreu V; Zhao X; Gastier-Foster JM; Lupo PJ; Neale G; Raetz E; Larsen E; Bowman WP; Carroll WL; Winick N; Williams R; Hansen T; Holm JC; Mardis E; Fulton R; Pui CH; Zhang J; Mullighan CG; Evans WE; Hunger SP; Gupta R; Schmiegelow K; Loh ML; Relling MV; Yang JJ
Nat Commun; 2015 Jun; 6():7553. PubMed ID: 26104880
[TBL] [Abstract][Full Text] [Related]
12. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
[TBL] [Abstract][Full Text] [Related]
13. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A.
Kumar R; Khan SP; Joshi DD; Shaw GR; Ketterling RP; Feldman AL
Pediatr Blood Cancer; 2011 Feb; 56(2):307-10. PubMed ID: 20973102
[TBL] [Abstract][Full Text] [Related]
14. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletions of CDKN2A are present in all dic(9;20)(p13·2;q11·2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation.
Zachariadis V; Schoumans J; Barbany G; Heyman M; Forestier E; Johansson B; Nordenskjöld M; Nordgren A
Br J Haematol; 2012 Nov; 159(4):488-91. PubMed ID: 22994152
[No Abstract] [Full Text] [Related]
16. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
[No Abstract] [Full Text] [Related]
18. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
19. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
Boldrin E; Gaffo E; Niedermayer A; Boer JM; Zimmermann M; Weichenhan D; Claus R; Münch V; Sun Q; Enzenmüller S; Seyfried F; Demir S; Zinngrebe J; Cario G; Schrappe M; Den Boer ML; Plass C; Debatin KM; Te Kronnie G; Bortoluzzi S; Meyer LH
Blood; 2021 Nov; 138(20):1953-1965. PubMed ID: 34098582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]